Bullpen.News From Edwin Dorsey
Get Daily Recap Feedback

Thursday, November 5, 2026

Back to the front page

From X

@ACapitalLP 2 clicks

A Capital on X

Two event-driven levered equities I’m thinking about this weekend: $XRX and $SVC. $XRX seems simple on paper. Monetize XFS, delever and unlock substantial equity value. But if it’s that obvious, why hasn’t Icahn’s guy done it in eight years? The recent TPG IP monetization suggests they’re willing to get creative, so what’s preventing an XFS transaction? $SVC is potentially more interesting. If the board accepts TKO’s $2bn hotel portfolio offer, you’re creating the remaining net lease portfolio at a very attractive valuation with significant equity torque from deleveraging. My biggest question is whether TKO actually has the financing commitments to close… Thoughts welcome.
@StableBread

Fajasy on X

85.5% of the BWX Technologies $BWXT stock insiders have sold in the open market since January 2025 came from CEO Rex Geveden. All 14 open-market transactions since then were sales, totaling 129,322 shares and $20.1M. Geveden accounts for 110,625 of the shares and $17.2M, in two phases: 1) Discretionary sales: 45,625 shares at $107.40 on February 26, 2025, and 25,000 at $179.00 on August 6, 2025, both two days after an earnings release and neither under a 10b5-1 plan (a pre-set trading plan). 2) Plan sales: On August 11, 2025, five days after the second sale, he adopted a 10b5-1 plan to sell up to 40,000 shares through August 14, 2026. He sold 10,000 shares/quarter under the plan, at $197.90, $203.26, $204.81, and $172.50, using up all 40,000. He still holds 192,491 shares directly ($28.0M at $145.70). The last two 10-Qs show no new plans adopted in H1 2026, and the Q3 10-Q, due with results on November 2, will show whether he adopted another plan after the first expired. The other eight sales, by seven executives and directors, totaled 18,697 shares and $2.9M. Most of this selling carries little signal. The other insiders’ $2.9M is small, and Geveden’s 40,000 plan shares were scheduled in August 2025. His two discretionary sales matter more. They totaled 70,625 shares ($9.4M) outside any plan, and including the plan sales, he’s sold about a third of his shares since February 2025. But both came right after $BWXT reported earnings, not ahead of them, at $107.40 and $179.00, well below the $238.42 peak. So the selling isn’t a warning sign, but with no insider buying during the drop, insiders aren’t signaling a bottom.
@ParadisLabs 1 click

Paradis on X

I think Gavin's correct. Open-weight models that compress frontier margins are positive for AI infra -- they don't shrink demand for compute. An example is after Deepseek R1, Tencent, Alibaba and Bytedance *significantly* increased H20 orders...and smaller healthcare & education firms started buying $NVDA H20's to run DeepSeek in-house. So we saw a broadening out of the customer base for the infra providers. In the West, I think $DELL is the best read on whether the buyer base is broadening beyond frontier labs. Hyperscalers mostly buy directly from Taiwanese ODMs, so Dell's AI customers are mostly neoclouds, sovereigns and enterprises. Dell's AI customer count went from >5,000 to >6,500 last quarter (30% growth in one quarter) which management say is mainly down to enterprise acceleration. Feels like that's one of the better public data points on how fast the self-hosting buyer base is growing. Which is a net-positive for AI infra. I don't understand how it can't be?

Investor Letters

All letters

Trading Post November 5, 2026

MercadoLibre’s logistics expansion cut margins by 60 basis points, while Mercado Pago grew credit 62% with 7% NPLs.

MELI $77B
Cassandra Unchained 2 clicks

Intel: The CPU Comeback, Discounted

Intel's Q3 2026 results were hit by memory costs and an Israel shutdown, but enterprise AI inference could lift CPU demand as server…

INTC $287B
Monte Independent Investment Research 2 clicks

Problems at Twist Bioscience (TWST)

Twist Bioscience’s $200 rebound followed an Anthropic-linked short squeeze, yet its DNA and protein services face broad competition while…

TWST $8B
Hunterbrook 4 clicks

VSH Earnings Review

Vishay reported record Q3 revenue of $979 million, up 24%, and guided Q4 to about $990 million as rising backlog and margins contrast with…

VSH $3.6B
Cestrian Capital Research 3 clicks

Thursday Tailwinds #13: Nov 5, 2026

Florida marinas are 92% full as boat counts rise and permits constrain new supply, creating pricing power for existing operators such as…

SUI $14B
Trade Ideas Flow 6 clicks

eToro: Expanding Beyond Crypto

EToro trades at 2.89x EV/FCF with $304 million in trailing free cash flow, expanding from crypto into equities, commodities, currencies and…

ETOR $1.9B
Max Arnoldi 5 clicks
SILC · long

Silicom LTD

Silicom (SILC) is pitched as inexpensive on its existing hardware business, with upside framed as a cheap call option.

SILC $183M
Value Investors Club 4 clicks

Research Note

Nine Mile Metals is the subject of a research note.

VMSXF $14M
Atrium Research - Equity Research 4 clicks

Publications we follow

Every publication on this site, hand-picked.

129 publications

Newsletters 109

YouTube 4

Blogs 15

Seeking Alpha 74 of 279

Nominate a publication

X accounts we follow

Every account on this site, hand-picked.

91 accounts
Nominate an account

Investor letters we follow

359 firms

Sectors

Ordered by how often our editor reaches for them.